glp-1 and skin sensitivity Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports - JDDonline glp 1 and skin sensitivity

Effective clearance of GL-3 in a human iPSC-derived cardiomyocyte model of Fabry disease

This study ultimately found that once-weekly subcutanoues Semaglutide was superior to placebo in improving body weight (~11% greater weight loss) and patient-oriented quality of life (QoL) outcomes including KCCQ-CSS and 6MWD at 52 weeks in HFpEF patients with obesity phenotype

Prefer at-home routines over clinical visits

BioFactors 40(1):2740 Fernndez-Snchez A, Madrigal-Santilln E, Bautista M, Jaime Esquivel-Soto J, Morales-Gonzlez A, Esquivel-Chirino C, Durante-Montiel I, Snchez-Rivera G, Valadez-Vega C, Morales-Gonzlez JA (2011) Inflammation, oxidative stress, and obesity